At the completion of this activity, participants will:
Identify risk factors in PWID to be re-infected by HCV after DAA treatment.
Describe how to prevent reinfection.
Explain HCV care model TEST TO CURE.
Presentation Summary: There are psychological and social vulnerabilities favouring re-infection of HCV through drug use. We presented results of a psychosocial study to understand why some HCV PWID were reinfected after HCV DAA treatment and others not.
.jpg "Andre Jean Remy, MD (he/him/his) photo")